Carisoprodol And Aspirin

   
Google
 
Web NewDrugInformation.com

Carisoprodol And Aspirin


Drug - Carisoprodol And Aspirin
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Aspirin; Carisoprodol
Multiple ingredients are in alphabetical order.

Strength - 325MG;200MG
The potency of the active ingredient(s), Aspirin; Carisoprodol. May repeat for multiple part products.

Applicant - PAR PHARM
The firm name holding legal responsibility for Carisoprodol And Aspirin. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 089594
The FDA assigned number to Carisoprodol And Aspirin. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Carisoprodol And Aspirin. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Mar 31, 1989
The date Carisoprodol And Aspirin was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Carisoprodol And Aspirin. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Carisoprodol And Aspirin is in. Format is RX, OTC, DISCN.

Applicant Full Name - Par Pharmaceutical Inc
The full name of the firm holding legal responsibility for the new application of Carisoprodol And Aspirin.

Carisoprodol And Aspirin